Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Park Medi WorldNSE:PARKHOSPS +1.84%20 Altman Z2-Score is 5.00 as of Jul. 21, 2026, which is 5% above its 10-year median of 4.75. GuruFocus rates NSE:PARKHOSPS with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 674 Healthcare Providers & Services companies, Park Medi World ranks better than 75.67% on this metric.
Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.
Good Sign:
Park Medi World has a Altman Z2-Score of 5.00, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.
The zones of discrimination were as such:
When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.
The historical rank and industry rank for Park Medi World's Altman Z2-Score or its related term are showing as below:
NSE:PARKHOSPS'
s Altman Z2-Score Range Over the Past 10 Years
Min: 4.49 Med: 4.75 Max: 5
Current: 5
During the past 4 years, Park Medi World's highest Altman Z2-Score was 5.00. The lowest was 4.49. And the median was 4.75.
Park Medi World (NSE:PARKHOSPS) Altman Z2-Score Explanation
The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
Altman Z2-Score does not apply to financial companies.
Park Medi World Altman Z2-Score Related Terms
Park Medi World Altman Z2-Score Historical Data
* Premium members only.
The historical data trend for Park Medi World's Altman Z2-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:PARKHOSPS vs HCA, THC, DVA: Altman Z2-Score Comparison
For the Medical Care Facilities subindustry, Park Medi World's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Park Medi World Altman Z2-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Park Medi World's Altman Z2-Score distribution charts can be found below:
* The bar in red indicates where Park Medi World's Altman Z2-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.
Park Medi World's Altman Z2-Score for today is calculated with this formula:
Z
=
6.56
*
X1
+
3.26
*
X2
+
6.72
*
X3
+
1.05
*
X4_2
=
6.56
*
0.1987
+
3.26
*
0
+
6.72
*
0.1038
+
1.05
*
2.8525
=
5.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.
Park Medi World (NSE:PARKHOSPS) has a Altman Z2-Score of 5.00 as of Jul. 21, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Park Medi World and its competitors. This is near median its historical median of 4.75. Over the past decade, Park Medi World's Altman Z2-Score has ranged from 4.49 to 5.00. According to the industry distribution chart, Park Medi World ranks #164 out of 674 companies in the Healthcare Providers & Services industry, placing it in the top 24.3%.
Is Park Medi World's Altman Z2-Score too high?
Park Medi World's current Altman Z2-Score of 5.00 is near median its 10-year median of 4.75. Over the past 10 years, this metric has ranged from a low of 4.49 to a high of 5.00. The Healthcare Providers & Services industry median Altman Z2-Score is 2.21. Park Medi World's value of 5.00 is 126.8% above this industry median. Based on the distribution chart, Park Medi World ranks #164 out of 674 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Park Medi World has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Park Medi World's Altman Z2-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Park Medi World ranks #164 out of 674 companies for Altman Z2-Score. This places Park Medi World in the top 24% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 2.21. Park Medi World's value of 5.00 is 126.8% above this benchmark. Historically, Park Medi World's own Altman Z2-Score has ranged from 4.49 to 5.00 over the past decade. While the company's 10-year median is 4.75 vs. the industry median of 2.21, Park Medi World has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Healthcare Providers & Services company?
The median Altman Z2-Score among Healthcare Providers & Services companies is 2.21, based on 674 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Park Medi World's current Altman Z2-Score of 5.00 is 126.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Park Medi World and its competitors. For the Healthcare Providers & Services industry, the median Altman Z2-Score is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Park Medi World's current Altman Z2-Score is 5.00, which is near median its own 10-year median of 4.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Park Medi World stock overvalued right now?
Park Medi World (NSE:PARKHOSPS) has a current Altman Z2-Score of 5.00. The current Altman Z2-Score is 5.00, which is near median its 10-year median of 4.75 and 126.8% above the Healthcare Providers & Services industry median of 2.21. Park Medi World's overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Park Medi World (NSE:PARKHOSPS), the current Altman Z2-Score is 5.00 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Park Medi World Ltd is a private hospital chain in North India with an aggregate bed capacity of 3,000 beds, and a private hospital chain in terms of bed capacity in Haryana with 1,600 beds. The company operates a network of 14 NABH accredited multi-super specialty hospitals under the Park brand, of which eight hospitals are also NABL accredited, with eight hospitals in Haryana, one hospital in New Delhi, three hospitals in Punjab and two hospitals in Rajasthan, each committed to providing high-quality and affordable medical services across a diverse range of specialties. It offers over 30 super specialty and specialty services, including internal medicine, neurology, urology, gastroentereology, general surgery, orthopedics and oncology.
20GF Score
Get the complete analysis for NSE:PARKHOSPS
Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PARKHOSPS has been successfully added to your 
